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Abstract
Background: The hypothesis of this study is that long-term high-fat diets (HFD) induce perivascular adipose tissue (PVAT)
dysfunction characterized by a redox imbalance, which might contribute to aggravate endothelial dysfunction in obesity.
Methods and Results: C57BL/6J mice were fed either control or HFD (45% kcal from fat) for 32 weeks. Body weight, lumbar
and mesenteric adipose tissue weights were significantly higher in HFD animals compared to controls. The anticontractile
effect of PVAT in mesenteric arteries (MA) was lost after 32 week HFD and mesenteric endothelial-dependent relaxation was
significantly impaired in presence of PVAT in HFD mice (Emax = 71.065.1 vs Emax = 58.564.2, p,0.001). The inhibitory effect
of L-NAME on Ach-induced relaxation was less intense in the HFD group compared with controls suggesting a reduction of
endothelial NO availability. Expression of eNOS and NO bioavailability were reduced in MA and almost undetectable in
mesenteric PVAT of the HFD group. Superoxide levels and NOX activity were higher in PVAT of HFD mice. Apocynin only
reduced contractile responses to NA in HFD animals. Expression of ec-SOD and total SOD activity were significantly reduced
in PVAT of HFD mice. No changes were observed in Mn-SOD, Cu/Zn-SOD or catalase. The ratio [GSSG]/([GSH]+[GSSG]) was 2-
fold higher in the mesenteric PVAT from HFD animals compared to controls.
Conclusions: We suggest that the imbalance between pro-oxidant (NOX, superoxide anions, hydrogen peroxide) and anti-
oxidant (eNOS, NO, ecSOD, GSSG) mechanisms in PVAT after long-term HFD might contribute to the aggravation of
endothelial dysfunction.
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Introduction
Perivascular adipose tissue (PVAT) is now considered a highly
active endocrine organ that releases a variety of adipokines,
inflammatory cytokines, and other factors which influence vascular
tone in a paracrine way [1,2]. Under physiological conditions
PVAT releases a number of vasoactive substances, such as
adipocyte-derived relaxing factor (ADRF) [3,4,5,6], adiponectin
[6], angiotensin-(1–7) [7], hydrogen peroxide (H2O2) [8], leptin
[9], and nitric oxide (NO) [10], that elicit a net beneficial anti-
contractile effect on vascular function and are essential for the
maintenance of vascular resistance [1,2,8].
The amount of PVAT can vary under different physiopatho-
logical conditions. Thus, its reduction in spontaneously hyperten-
sive rats [5,9,11] or in lipoatrophic mice [12] has been shown to
correlate with a reduction in the production of vasodilator
adipokines and also with an increase in contractile responses
[5,9,11] and blood pressure [12]. To the contrary, a moderate
enlargement of PVAT is associated with an increase of vasodilator
adipokines [10]. In this context, we have shown that a short-term
HFD triggers NO overproduction in PVAT contributing to the
improvement of mesenteric vasodilator responses [10].
However, changes in PVAT quantity are not solely responsible
for changes in vascular function. In established obesity, there
might be also changes in the expression pattern of adipokines and
other PVAT-derived factors, which shift the paracrine influence
from a net anti-contractile effect to a pro-oxidant, pro-inflamma-
tory and contractile environment [2]. In this context, Gao et al
[13] demonstrated in a pharmacological model of obesity a loss of
the anti-contractile effect of periaortic adipose tissue. New Zealand
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obese mice, which exhibit polygenic obesity associated to most
symptoms of the metabolic syndrome, show a poor anti-contractile
effect of mesenteric PVAT [6] together with increased NADPH
oxidase activity and superoxide production (O2
-) [14]. Similarly,
short-term very HFD (60% cal from fat) has been shown to
enhance both O2
- and H2O2 levels, as well as Nfc2 expression in
periaortic adipose tissue [15]. In obese patients, a loss of the dilator
effect of PVAT together with an increase in adipocyte area and
higher expression of inflammatory markers has been reported
[16].
In any case, most of the precedent findings have been identified
after short-term HFD treatments and on periaortic adipose tissue,
which exhibits typical characteristics of brown adipose tissue in
contrast to the white phenotype of mesenteric PVAT [11].
Moreover, most studies focus on the up-regulation of pro-oxidant
mechanisms (production of O2
- and H2O2, increase of NADPH
oxidase activity, etc) but do not deal with eventual alterations in
PVAT anti-oxidant mechanisms. Because redox alterations result
from the imbalance between pro- and anti-oxidant mechanisms,
our hypothesis is that long-term HFD induces a mesenteric PVAT
dysfunction, which is characterized by a down-regulation of
antioxidant together with the up-regulation of pro-oxidative
mechanisms and leads to a loss of PVAT anticontractile effect
aggravating endothelial dysfunction in resistance arteries. We have
determined in mesenteric PVAT from mice receiving a HFD
during 32-week: i) nitric oxide (NO) and superoxide anion (O2
-)
availability, ii) eNOS expression, iii) NADPH oxidase (NOX) and
total superoxide dismutase (SOD) activities, iv) Cu/Zn-SOD, Mn-
SOD and ec-SOD isoforms, v) catalase and levels of reduced
glutathione, and vi) the role of PVAT on vascular function.
Materials and Methods
Animals and dietary treatment
Four-week old male C57BL/6J mice (Harlan, Spain) weighing
16–18 g were housed under controlled light (12-hour light/dark
cycles from 8:00 am to 8:00 pm) and temperature (22–24uC)
conditions with standard food and water ad libitum. After one week,
animals with similar average body weight, were divided into two
groups, housed 8–10 per cage, and assigned either to a control or
to a high-fat diet (HFD). Control (D12450B, 10 kcal % fat, 70 kcal
% carbohydrates and 20 kcal % protein; 3.85 kcal/g) and HFD
(D12451, 45 kcal % fat, 35 kcal % carbohydrates, 20 kcal %
protein; 4.73 kcal/g) diets were supplied by Test Diet Limited
BCM IPS Ltd (London, UK). HFD and their respective control
mice had free access to food during 3261 weeks. On the last day,
mice were weighed and systolic (SBP) and diastolic (DBP) blood
pressure were determined through a cannula inserted in the right
carotid artery connected to a pressure transducer (Statham,
Harvard Apparatus GmbH, Germany). All surgery was performed
under anaesthesia (80 mg?kg-1 ketamine hydrochloride and
12 mg?kg-1 xylazine hydrochloride) and all efforts were made to
minimize suffering. SBP and DBP were recorded in a PowerLab
system (ADInstruments). The mesenteric bed was immediately
dissected. In addition, mesenteric and lumbar adipose tissue were
weighed and normalized by tibia length. Blood was collected in
chilled EDTA-coated polypropylene tubes in the morning. 24-
hour fasting was avoided since fasting stimulates lipid mobilization,
lipolysis and a reduction of mesenteric perivascular adipose tissue
amount [5]. Biochemical values represent therefore postprandial
concentrations. Plasma samples were frozen for biochemical
determinations and isolated mesenteric arteries were used for
confocal imaging studies and were also frozen at 280uC for
western blot analysis. The investigation conforms to the Guide for
the Care and Use of Laboratory Animals published by the US
National Institute of Health (NIH publication No. 85-23, revised
1996) and was approved by the university ethics review board
(Comite´ de Experimentacio´n Animal de la Universidad Complu-
tense de Madrid CEA-24-10-2008).
Adipocyte diameter determination by confocal
microscopy
Adipocyte diameter was assessed in fresh adipose tissue by
confocal microscopy based on adipocyte autofluorescence. The
size of the fat cell was measured by direct microscopic
determination, and the mean adipocyte diameter was calculated
from measurements of 100 cells per animal [5].
Vascular reactivity in the perfused mesenteric vascular
bed and in isolated mesenteric arteries cleaned of PVAT
Vascular reactivity experiments were performed as previously
described [10]. Briefly, MB was perfused at a constant flow (1.5 ml
min21) with oxygenated (95% O2/5% CO2) Krebs-Henseleit
solution (KHS, in mM, 115 NaCl, 4.6 KCl, 2.5 CaCl2, 25
NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, 0.01 EDTA and 11.1
glucose). After equilibration (40 min), vascular contractility was
assessed with 75 mM KCl. Contractile responses were determined
with noradrenaline (NA, 0.1–10 mM). Relaxant responses to
acetylcholine (Ach, 1 nM–0.1 mM) and sodium nitroprusside
(SNP, 0.001 nM–10 mM) were analysed in vessels pre-contracted
with NA (10 mM), which elicited a submaximal contraction of 90%
Emax. Although 0.1 mM NA elicited maximal contraction we did
not add this concentration since the bed desensitized. The nitric
oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-
NAME, 0.1 mM), the radical scavenger, apocynin (0.1 mM) and
the catalase inhibitor, 3-amino-1,2,4-triazole (3-AT, 20 mM) were
pre-incubated for 20 min.
Isolated mesenteric arteries were mounted on 25 mm wires in a
wire myograph (Danish Myotech, Aarhus, Denmark). After
30 min incubation, vessel wall tension and diameter were
normalized following a standardized method described by
Mulvany and Halpern [17]. After equilibration, vascular contrac-
tility was assessed with 75 mM KCl. Contractile responses were
determined with NA (1 nM–10 mM). Relaxant responses to Ach
(1 nM–0.1 mM) were analysed in MA, pre-contracted with NA
(1 mM–3 mM) which elicited a submaximal contraction of 90%
Emax. L-NAME (0.1 mM), apocynin (0.1 mM) and 3-AT
(20 mM) were pre-incubated for 20 min.
Determination by confocal microscopy of basal NO and
O2
.- availability
NO availability was determined with the fluorescent NO
indicator 4,5-diaminofluorescein diacetate (DAF-2DA) [18]. Ad-
ipose tissue-free first-order MA and PVAT were stabilized in
Krebs solution (30 min, 37uC), then stained with DAF-2DA
(10 mM), fixed in 4% paraformaldehyde (PFA) and mounted intact
(3 mm length segments) in a small well as previously described
[18]. Negative and positive controls were incubated with either L-
NAME (0.1 mM) or superoxide dismutase (SOD, 15 U/ml),
respectively. Under our conditions, PFA fixation did not affect
DAF-2DA fluorescence [18]. Confocal projections of the MA and
PVAT were then obtained and intensity levels quantified with
Metamorph image analysis software (Universal Imaging Corpo-
ration, Buckinghamshire, UK).
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Basal O2
- availability in MA and PVAT was determined with
dihidroethidium (DHE, 3 mM) [18]. DHE permeates the cell and
is directly oxidized by superoxide anion resulting in the generation
of ethidium bromide, that combined with DNA is trapped in the
nucleus and emits an intense red fluorescence. MA segments and
PVAT were treated and analysed as previously described for DAF-
2 DA protocol. Negative controls were incubated throughout the
experimental period with SOD (15 U/ml).
NADPH oxidase (NOX) and total superoxide dismutase
(SOD) activities
NOX activity was measured in first-order MA segments and
mesenteric PVAT by using the lucigenin-enhanced chemilumi-
nescence method [18]. Total SOD activity was also determined in
these tissues by a modified nitroblue tetrazolium (NBT)-based
spectrometric assay [19] that includes bathocuproine sulfonate
(BCS) as chelator agent and inhibitor of mitochondrial electron
transport chain, and xanthine oxidase [19]. Briefly, 126 ml BCS/
NBT mixture (1 ml BCS 0.13 mM+34.5 ml NBT 2.6 mM) were
mixed with 20 ml MA or PVAT homogenate, 20 ml buttermilk
xanthine oxidase (0.126 U/ml) and 20 ml potassium phosphate
buffer (50 mM, pH 7.5). The mixture was incubated at 37uC and
14 ml xanthine (2.1 mM) were added. The formazan formation
reaction was monitored for 20 min at 630 nm by using a
microplate reader programmed in kinetic mode. The absorbance
change rate (S) was calculated as the slope of the absorbance vs the
reaction time, by using a linear regression analysis. SOD activity
was expressed in U/mg protein, which was estimated from the
SOD standard curve (0–6 U/ml) obtained as the S0/S ratio vs the
enzyme concentration, being S0 the slope of the uninhibited
(without SOD) reaction.
Table 1. Effect of dietary treatment on body weight, adiposity and plasma parameters.
Control diet High-fat diet
Body Weight (g) 31.460.9 46.460.7 ***
Tibial length (mm) 20.360.1 20.360.2
SBP (mm Hg) 85.766.3 90.165.5
DBP (mm Hg) 63.865.1 60.662.4
Lumbar adipose tissue (mg/mm) 14.161.5 36.264.0 *
Mesenteric adipose tissue (mg/mm) 19.162.7 44.863.6 ***
Adipocyte diameter (mm) 62.3362.3 113.15610***
Leptin (ng/ml) 13.662.0 28.466.1 *
Adiponectin (mg/ml) 9.960.4 7.860.4 ***
Insulin (mg/ml) 2.160.3 6.160.5 ***
Glucose (mg/dl) 191.5628.4 236.9625.3 *
Triglycerides (mg/dl) 79.663.6 81.563.0
Adipose tissue weights were normalized by using tibia length as reference. Values are mean 6 S.E.M.; n = 16 determinations/group. *p,0.05, ***p,0.001, compared to
their corresponding matched control groups. Newman Keuls’ test.
doi:10.1371/journal.pone.0095312.t001
Figure 1. Effect of PVAT on contractile responses to noradrenaline. Cumulative concentration-response curves to noradrenaline (NA, 1 nM–
10 mM) in MA with (+) and without (2) PVAT from control (C) [A] and high fat diet (HFD) animals [B]. Data are means 6 S.E.M. (n$5 animals per
group). **p,0.01, compared to MA (-) PVAT. Cumulative concentration-response curves to NA (0.1–10 mM) in MB from C and HFD animals [C]. Data
are means 6 S.E.M. (n$5 animals per group). **p,0.01, compared with C.
doi:10.1371/journal.pone.0095312.g001
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Western blot of endothelial (eNOS), SOD isoforms and
catalase (CAT)
Amounts of Cu/Zn-SOD, Mn-SOD, ec-SOD and CAT, eNOS
and phosphorylated eNOS (p-eNOS) were quantified in adipose
tissue-free MA and PVAT. Western blotting was performed as
previously described [20]. Briefly, 30 mg protein samples were
separated by 10% (eNOS and p-eNOS) or 15% (Cu/Zn-SOD,
Mn-SOD, ec-SOD and CAT) SDS-PAGE gels. Primary antibod-
ies against e-NOS (BD Transduction Laboratories, Lexington,
UK; 1:1000 final dilution), p-eNOS (Ser-1177) (Cell Signalling
Technology, USA; 1:500 final dilution), Cu/Zn-SOD (Santa Cruz
Biotechnology, Germany; 1:2000 final dilution), Mn-SOD (Santa
Cruz Biotechnology, Germany; 1:2000 final dilution), ec-SOD
(StressGen; USA; 1:1000 final dilution) and CAT (Sigma-Aldrich,
Spain; 1:2000 final dilution) were applied overnight at 4uC. After
washing, appropriate secondary antibodies (anti-rabbit or anti-
mouse IgG-peroxidase conjugated) were applied for 1 h. Blots
were washed, incubated in commercial enhanced chemiluminis-
cence reagents (ECL, Amersham Bioscience, UK) and exposed to
autoradiographic film. To prove equal loadings of samples, blots
were re-incubated with b-actin antibody (Affinity Bioreagents,
USA). Films were scanned using a GS-800 Calibrated Densitom-
eter (Bio-Rad, Spain) and blots were quantified using Quantity
One software (Bio-Rad, Spain). Expression values of peNOS were
normalized with eNOS and expression values of Cu/Zn-SOD,
Mn-SOD, ec-SOD and CAT were normalized with b-actin, to
account for variations in gel loading.
Chemicals
Ach was dissolved in saline. NA and SNP were dissolved in
0.01% ascorbic acid/saline. L-NAME, 3-AT and apocynin were
dissolved in distilled water. DHE was dissolved in dimethylsulf-
oxide (DMSO) and was kept in dark conditions under argon. Ach,
SNP, L-NAME, 3-AT, apocynin, DAF-2DA and DHE were
obtained from Sigma Aldrich.
Statistical analysis
All values are given as mean6 SEM. Statistical significance was
analysed by one-way ANOVA or two-way ANOVA followed by
Newman-Keuls post-hoc test. Statistical significance was set at p,
Figure 2. Contribution of endothelial nitric oxide to Ach-mediated relaxant responses. Cumulative concentration-response curves to
acetylcholine (Ach, 1 nM–0.1 mM) in MB [A] and in MA [B] from control (C) and high fat diet (HFD) animals in absence/presence of L-NAME (0.1 mM).
Data are means 6 S.E.M. (n$5 animals per group). ***p,0.001;**p,0.01, compared to C; ###p,0.001 compared to their corresponding matched
control groups.
doi:10.1371/journal.pone.0095312.g002
Table 2. Emax and pD2 values of Ach-induced relaxation in mesenteric arteries (MA-PVAT) and in the perfused mesenteric bed
(MB).
Control diet High-fat diet
Emax pD2 AUC Emax pD2 AUC
Ach (MA) 87.063.1 6.160.1 200.6617.2 71.065.1# 5.860.2 149.7623.9
Ach+L-NAME (MA) 20.569.2*** 5.760.4 42.1626.1** 30.7615.6*** 5.760.4 87.5644.6
Ach (MB) 93.662.8 7.660.2 346.6611.5 58.564.2### 7.160.3 197.2622.8###
Ach+L-NAME (MB) 31.269.1*** 6.960.7 98.5631.3*** 22.960.9### 6.660.3 78.367.5***
MA (Isolated mesenteric arteries), MB (perfused mesenteric bed). Emax, is the maximal relaxation to acetylcholine in % of precontraction to noradrenaline. pD2, is the
negative logarithm of molar concentration of Ach causing half maximal responses. AUC, is the area under concentration-response curves expressed in mmHg for MB
and mg for MA. Data are expressed as mean 6 S.E.M., n$5. **p,0.01, ***p,0.001, compared to their corresponding matched control groups. #p,0.05, ###p,0.001
compared to the control group.
doi:10.1371/journal.pone.0095312.t002
Perivascular Adipose Tissue Dysfunction in Obesity
PLOS ONE | www.plosone.org 4 April 2014 | Volume 9 | Issue 4 | e95312
0.05. n represents the number of data. Contractions are expressed
in mm Hg in the perfused MB, and in mN in isolated mesenteric
arteries. Relaxations are expressed as the percentage of a previous
NA contraction. The maximum response (Emax) and the negative
log of the concentration producing 50% of the maximum response
(pD2) were calculated by a non-linear regression analysis of each
individual concentration-response curve. Area under the concen-
tration-response curves (AUCs) were calculated from the individ-
ual concentration-response curve plots.
Figure 3. Nitric oxide and superoxide anion availability in mesenteric arteries. [A] Confocal projections showing in situ NO generation,
determined with DAF2-DA (1025 M), in MA. Adventitial cells are round; vascular smooth muscle cells are elongated and perpendicular to blood flow;
endothelial cells are elongated and parallel to blood blow. [B] Fluorescence intensity in MA from control (C) and high fat diet (HFD) animals. Data are
means 6 S.E.M. (n$5 animals per group). ***p,0.001 compared to C. [C] Confocal projections showing in situ superoxide generation determined
with dihydroethidium (DHE, 3 mM) in MA and [D] quantification of DHE fluorescence intensity in MA from C and HFD. Data are means 6 S.E.M. (n = 5
animals per group). ***p,0.001 compared to C.
doi:10.1371/journal.pone.0095312.g003
Figure 4. eNOS phosphorylation and NOX activity in mesenteric arteries. [A] Representative immunoblots of p-eNOS in MA. Diagram bars
show the result of densitometric analysis of p-eNOS immunoblots, expressed as percentage of p-eNOS/eNOS in the control (C) group. Data are means
6 S.E.M. (n$5 animals per group). *p,0.05 compared to C. [B] NOX activity in MA. Results are expressed as percentage of NADPH oxidase activity in
C animals. Data are means 6 S.E.M. (n$5 animals per group). *p,0.05 compared to C.
doi:10.1371/journal.pone.0095312.g004
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Results
Physiological variables after 32 week HFD
Body weight (BW), lumbar and mesenteric adipose tissue
weights were significantly higher in HFD animals compared to
controls (Table 1). Mesenteric adipocyte diameter was significantly
higher in HFD compared to control. HFD induced an increase in
leptin, insulin and glucose plasma concentrations, together with a
reduction in adiponectin plasma levels (Table 1). Both systolic and
diastolic blood pressure levels were similar between groups.
Anticontractile effect of PVAT is lost after 32 week HFD
In the mesenteric bed (MB), basal perfusion pressure (con-
trol = 14.062.2 mm Hg; HFD=14.761.6 mm Hg) and contrac-
tion to 75 mM KCl (control = 44.6610.6 mm Hg;
HFD=38.866.8 mm Hg) were similar between groups. In
control mice, vasoconstriction to noradrenaline (NA, 1 nM–
10 mM) was smaller in mesenteric arteries (MA) with PVAT than
in cleaned arteries (Figure 1A). On the contrary, the presence of
PVAT did not modify contraction to NA in MA of HFD mice
(Figure 1B). In the MB, contractions to NA (0.1–10 mM) were
significantly more intense in HFD than in the control group
(Figure 1C; one-way ANOVA, F(1,50) = 8.742, p,0.01).
Mesenteric endothelial dysfunction is aggravated in
presence of PVAT after 32 week HFD
Basal perfusion pressure (C= 14.062.2 mm Hg;
HFD=14.761.6 mm Hg) and contractions to 75 mM KCl
(C= 44.6610.6 mm Hg; HFD=38.866.8 mm Hg) were similar
between control and HFD groups suggesting no mechanic
interference of PVAT amount in the HFD group.
Relaxation to Ach (1 nM–0.1 mM) was impaired in the MB of
the HFD group (Figure 2A, Table 2; one-way ANOVA,
F(1,60) = 113.1, p,0.001). In presence of the NOS inhibitor, L-
NAME (0.1 mM), relaxations to Ach were similar between groups
(Figure 2A, Table 2). However, the inhibitory effect of L-NAME
on Ach-induced relaxation was less intense in the HFD group
compared with controls (two-way ANOVA, F(1,84) = 18.5, p,
0.001), suggesting a reduction of endothelial NO availability in
HFD. Indomethacin (3 mM) or indomethacin (3 mM) plus L-
NAME (0.1 mM) similarly affected control and HFD MB
reactivity to Ach, demonstrating that the contribution of
prostanoids and EDHF to Ach-induced relaxation were not
modified by HFD (results not shown). Moreover, relaxation
to SNP (0.001 nM–10 mM) was similar in both groups
(Emax Control = 90.563.7%; Emax HFD= 90.662.0%), indicating
that the activity/sensitivity of the soluble guanilylcyclase is not
modified by long-term HFD.
Relaxation to Ach in MA was also significantly reduced in HFD
animals (Figure 2B, table 2, one-way ANOVA, F(1,48) = 10.5, p,
Figure 5. Contribution of pro-oxidant systems on contractile responses to noradrenaline in both mesenteric arteries and the
mesenteric bed. [A] Confocal projections showing in situ superoxide generation determined with dihydroethidium (DHE, 3 mM) in mesenteric PVAT
from control (C) and high fat diet (HFD) animals. [B] NOX activity in mesenteric PVAT. Results are expressed as percentage of NOX activity in C. Data
are means 6 S.E.M. (n$5 animals per group). *p,0.05 compared to C animals. [C] Cumulative concentration-response curves to noradrenaline (NA,
0.1–10 mM) in MB and [D] cumulative concentration-response curves to NA (1 nM–10 mM) in MA from C and HFD animals in absence/presence of
apocynin (0.1 mM). Data are means 6 S.E.M. (n$5 animals per group). #p,0.05; ###p,0.001 compared to their corresponding matched control
groups.
doi:10.1371/journal.pone.0095312.g005
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0.01). However, the impairment of relaxation was significantly
higher in the MB than in cleaned MA (20%, two-way ANOVA,
F(1,108) = 19.5, p,0.001), suggesting an important contribution of
PVAT to endothelial dysfunction.
Preincubation with L-NAME significantly reduced relaxation to
Ach in MA of both groups (one-way ANOVA, F(1,30) = 3.5; p,
0.001), although inhibition in the HFD group was lower compared
to controls (two-way ANOVA, F(1,96) = 11.7, p,0.001). Concen-
tration-response curves to SNP (0.001 nM–10 mM) were similar
between groups (results not shown) excluding changes in smooth
muscle sensitivity.
Endothelial NO availability is reduced due to an increase
in superoxide anion levels in isolated MA
In order to confirm changes in endothelial NO availability
suggested by vascular reactivity studies, basal endothelial NO
availability in MA devoid of PVAT was determined with the
fluorescent NO indicator, DAF-2DA. As expected, fluorescence
intensity emitted by MA was significantly lower in HFD animals
than in controls (Figure 3A and 3B, one-way ANOVA,
F(1,19) = 39.6, p,0.001). To the contrary, basal level of O2
-
determined by quantifying DHE fluorescence intensity (Figure 3C
and D), was more than 2-fold higher in MA from the HFD group
(one-way ANOVA, F(1,29) = 29.5; p,0.001).
Western blot revealed that basal level of phosphorylated eNOS
(p-eNOS-Ser1177) was significantly lower in HFD animals
(Figure 4A; one-way ANOVA, F(1,14) = 7.8, p,0.05).
Moreover, we detected a significant increase in NOX activity in
MA from HFD animals (Figure 4B) which explains the increase in
O2
.-. Altogether, these data demonstrate that reduction in NO
availability in MAs from HFD results from both a reduced NO
production together with a higher NO inactivation by the increase
of oxidant species.
A negative correlation was found between DAF-2DA-induced
fluorescence intensity and plasma leptin levels (p,0.01; r = 0.7;
F(1,14) = 13.3) together with a positive correlation between DAF-2
DA-induced fluorescence intensity and plasma adiponectin levels
(p,0.001; r = 0.82; F(1,21) = 43.6). Similarly, we also found a
negative correlation between plasma leptin and p-eNOS (p,
0.001; r = 0.93; F(1,14) = 82.5), and a positive correlation between
plasma adiponectin and p-eNOS (p,0.01; r = 0.74; F(1,14) = 16.7).
To the contrary, DHE fluorescence intensity negatively and
positively correlated with adiponectin (p,0.001; r = 0.8;
F(1,21) = 36.2) and leptin (p,0.01; r = 0.73; F(1,14) = 15.7), respec-
tively.
Figure 6. Contribution of antioxidant systems on contractile responses to noradrenaline in both mesenteric arteries and the
mesenteric bed. Effect of HFD on ec-SOD protein expression in mesenteric PVAT [A] and in MA [B]. Diagram bars show the result of densitometric
analysis of ec-SOD immunoblots, expressed as percentage of ec-SOD in the control (C) group. Data are means 6 S.E.M. (n$5 animals per group).
Total SOD activity in mesenteric PVAT [C] and in MA [D]. Data are presented as means 6 S.E.M. (n$5 animals per group). *p,0.05 compared to C
animals. [E] Cumulative concentration-response curves to noradrenaline (NA, 0.1–10 mM) in MB and [F] cumulative concentration-response curves to
NA (0.1–10 mM) in MA from C and HFD animals in absence/presence of 3-amino-1,2,4-triazole (3-AT, 20 mM). Data are means 6 S.E.M. (n$5 animals
per group). ##p,0.01; ###p,0.001 compared to their corresponding matched control groups.
doi:10.1371/journal.pone.0095312.g006
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PVAT NOX activity and superoxide anion levels are
increased after long-term HFD
To better identify the mechanisms involved in the reduction of
the PVAT-derived anticontractile effect previously observed in
HFD animals, both pro-oxidant and anti-oxidant mechanisms
were evaluated. PVAT from HFD animals exhibited a significant
increase in DHE-induced fluorescence co-localizing with nuclei
DAPI-staining (Figure 5A). NOX activity (Figure 5B) was 3.5-fold
higher in HFD mice. Moreover, the ratio [GSSG]/([GSH]+
[GSSG]) was 2-fold higher in the mesenteric PVAT from HFD
animals compared to controls (C= 22.268.6% vs
HFD=55.566.6%; one-way ANOVA, F(1,7) = 9.8, p,0.05), thus
demonstrating an increased contribution of pro-oxidant systems.
However, NO availability in PVAT was almost undetectable and
similar between groups (C=21.164.4 vs HFD=20.461.1), as
well as eNOS expression and phosphorylation (p-eNOS) (results
not shown).
Role of increased adipose oxidative stress on vascular
responses
The contribution of O2
- to NA-induced responses was evaluated
in absence or presence of apocynin (0.1 mM), a scavenger of
radicals and direct inhibitor of ROS-induced signaling in vascular
cells [21]. Contractions to NA were significantly higher in the
HFD group compared to controls (one-way ANOVA, F(1,60) = 8.0,
p,0.01; Figure 5C and D). Apocynin only reduced the contractile
responses to NA in HFD animals (two-way ANOVA, F(1,80) = 4.1;
p,0.05; Figure 5C and 5D). This effect was more pronounced in
presence of PVAT, suggesting that the paracrine contribution of
O2
- to endothelial dysfunction was enhanced in this group.
Long-term HF diet reduces ec-SOD expression and SOD
activity in PVAT
The expression of the SOD isoforms, Cu/Zn-SOD and Mn-
SOD, in mesenteric PVAT and in MA was similar between groups
(results not shown). No differences were observed between groups
and tissues in catalase levels (C= 100.0610.2% vs
HFD=118.1266.0%; one-way ANOVA, F(1,12) = 2.4, p = 0.15).
In contrast, ec-SOD expression was significantly reduced in PVAT
of HFD mice (Figure 6A) with no differences in MA between
groups (Figure 6B). Total SOD activity was significantly reduced
in PVAT, but significantly increased in MA of HFD animals
(Figures 6C and 6D).
The contribution of H2O2 to NA-induced responses was
evaluated in absence or presence of the catalase inhibitor, 3-
amino-1,2,4-triazole (3-AT, 20 mM), which selectively inhibits
catalase activity at concentrations as high as 50 mM [22]. In the
MB, the contractile response to NA (0.1–10 mM) was significantly
reduced in both groups (2-ANOVA, F(1,80) = 13.757, p,0.001)
although it was more pronounced in the HFD group (Figure 6E).
However, while the contractile response to NA (1 nM–10 mM) was
significantly reduced in the MA of both groups, no differences
were detected between control and HFD animals (Figure 6F).
Discussion
In this study we show for the first time that long-term HFD
induces PVAT dysfunction characterized by i) a substantial
reduction in eNOS and NO production, ii) a decrement in ec-
SOD expression and total SOD activity, and iii) an increase of
NOX activity and superoxide anion release. Moreover, our study
provides the first evidence of ec-SOD expression in PVAT as well
as its different regulation between PVAT and the vascular wall in
obesity. We suggest that the imbalance between antioxidant and
pro-oxidant mechanisms in PVAT evoked by long-term HFD
might contribute to vascular oxidative stress, thus aggravating
endothelial dysfunction.
Vascular function assays, carried out in both isolated mesenteric
artery (MA) and in the whole mesenteric bed (MB), suggest that
PVAT elicits an anti-contractile effect that positively correlates
with the amount of adipose tissue surrounding the artery (PVAT in
first-order MA branches is about 4–6 mg/2 mm segment artery vs
372652 mg PVAT in MB), as we had previously suggested [5,10].
To better highlight changes in PVAT properties in HFD mice, we
compared between responses in the intact MB and in first-order
MA cleaned from fat. We are aware that this is a limitation of the
study since functional characteristics of MA and MB are different.
Figure 7. Representative diagram with a possible mechanism explaining the effect of long-term high fat diet (HFD) on endothelial
dysfunction. Adipokine dysregulation in PVAT (increase in leptin release together with reduced adiponectin levels) lead to an increase in NOX
activity but a reduction in total SOD activity and ec-SOD expression. Therefore, obesity induces a huge increment of superoxide levels in PVAT.
Circulating and PVAT-derived adipokines might also lead to an increased NOX activity and consequently, to enhance superoxide and H2O2 levels in
the vascular wall. PVAT-derived adipokines might also contribute to a reduction in eNOS phosphorylation and, consequently to reduced NO
availability that accounts for endothelial dysfunction aggravated by PVAT-derived superoxide.
doi:10.1371/journal.pone.0095312.g007
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To validate functional results, expression studies (SODs, NOX,
catalase), glutathione, NO and superoxide level determination and
enzyme activity measurements (total SOD and NOX) were
quantified in first-order MA with and without PVAT.
In our long-term HFD model we observed a substantial
endothelial dysfunction in absence of PVAT, as previously
described in experimental models of obesity [23]. The endothelial
dysfunction was associated to a reduced endothelial p-eNOS and
NO availability, which was independent of EDHF, prostanoids or
smooth muscle sensitivity to NO, but linked to an increase in
NOX activity and O2
- levels. O2
.- concentration depends on the
balance between its production and dismutation rate by the
various superoxide dismutases (SODs), the copper-zinc SOD (Cu/
Zn-SOD), the manganese SOD (Mn-SOD), and the extracellular
form of Cu/Zn-SOD (ec-SOD). In the vascular wall, total SOD
activity appeared to be increased, probably aimed to compensate
increased O2
.-. In these context, preincubation with apocynin
(10 mM) reduced contractions to NA in HFD but not in controls,
suggesting that the increase in total SOD activity is insufficient to
compensate NO reduction and endothelial dysfunction in HFD.
Endothelial dysfunction was aggravated in presence of PVAT,
suggesting that its beneficial anti-contractile effect observed after
short-term HFD [10] is lost after 32-week HFD. The deleterious
influence of PVAT might be the result of i) the down-regulation of
both eNOS expression and NO production (that reaches almost
undetectable levels), ii) the increase in NOX activity and O2
- levels
and iii) down-regulation of ec-SOD and total SOD activity. The 2-
fold increase in GSSG/(GSH/GSSG) ratio detected in HFD
might be aimed at compensating oxidative damage, but seems,
however, to be insufficient to balance the increase in O2
.-
availability and endothelial dysfunction. Changes observed in
PVAT and in vascular function might be primary due to HFD or
secondary to obesity. Our model cannot be strictly considered as a
model of metabolic syndrome, as DIO mice did not display
hypertension. Otherwise, as previously reported by ourselves, 32-
wk HFD leads to insulin resistance, moderate hyperleptinemia and
hepatic steatosis. Nevertheless basal levels of trigycerides and free
fatty-acids were not different between controls and HFD mice
[24]. However, we cannot exclude that hyperinsulinemia and/or
hyperglycaemia could trigger vascular damage, thus contributing
to vascular dysfunction, independently of the effect of PVAT.
The presence of ec-SOD in PVAT constitutes a novelty itself, as
this enzyme had never been identified previously in PVAT. In fact
ec-SOD, synthetized by fibroblast and smooth muscle cells [25],
had been previously identified as a pivotal element to protect the
vascular wall from O2
.-, thus allowing endothelial NO to reach the
vascular smooth muscle layer [26]. Reduced ec-SOD expression
has been associated with pathological conditions affecting vascular
function, such as atherosclerosis or coronary artery disease [27].
However, deficiency in ec-SOD does not alter baseline blood
pressure [28] http://atvb.ahajournals.org/cgi/content/full/24/
8/1367 - R93-015610#R93-015610, despite increased vasocon-
strictor responses [29], as we also can observe in our model.
A pivotal question evoked by our study deals with the ability of
PVAT O2
.-, which displays a short half-life and low diffusion
radius, to reach the media and the endothelium. We propose two
possible answers. First, O2
.- is rapidily converted to H2O2, which is
cell-permeable and highly stable [30]. H2O2 is able to exert
paracrine vasoactive and structural effects in the media indepen-
dently of its source, i.e. adventitia, intima or PVAT [31,32]. Here,
the overall contribution of H2O2 to vascular function was higher in
presence of PVAT in the HF group (Figure 6) since it is the sum of
H2O2 derived from both PVAT (although lower than in the
control group) and the vessel wall. Secondly, in a context of high
O2
.- availability due to an increased NOX and a reduced SOD
activity, as well as lack of NO, we cannot exclude the possibility of
O2
.- diffusion contributing to reduce endothelial NO availability in
a paracrine way (Figure 7).
A further question raised by our data concerns the eventual
influence of hyperleptinemia and/or hypoadiponectinemia on
vascular O2
- and H2O2 production. Leptin has been shown to
increase NOX activity and O2
- production in the vascular wall as
well as to promote GPx activation to remove excessive H2O2
production [33,34]. Moreover, hypoadiponectinemia is closely
associated with endothelial dysfunction in humans [35] and
adiponectin knock-out mice show reduced p-eNOS levels [36].
Interestingly, the reduction of adiponectin expression in an
adipocyte cell line parallels the down-regulation of ec-SOD and
plasma ec-SOD levels inversely correlate with body mass index
[37].
In conclusion, we provide new evidence that PVAT dysfunction
after a long-term HFD contributes to a deficient management of
perivascular adipose superoxide that aggravates endothelial
dysfunction. Our results suggest that endothelial dysfunction
triggered by HFD is aggravated by the increase of oxidative stress
in PVAT, describing a role for ec-SOD in this altered redox
balance. Altogether, these findings demonstrate that changes in
the expression pattern of PVAT-derived anti-oxidant and pro-
oxidant factors shift the paracrine influence of PVAT from a net
anti-contractile effect to a pro-oxidant, pro-inflammatory and
contractile environment and support a prominent influence of
mesenteric PVAT in endothelial dysfunction in diet-induced
obesity, as previously suggested for periaortic adipose tissue
[13,15,16].
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